Manufacturing

Opus enters a strategic collaboration with Resilience for AAV-based gene therapy development and manufacturing for inherited retinal diseases.

Lonza and Asher Biotherapeutics have entered a manufacturing agreement for a cis-targeted IL-2 fusion protein, AB359.

IAVI and Moderna have announced a new collaboration to employ mRNA technology to meet the challenge of a range of global health issues.

WeylChem has put a new multi-purpose custom manufacturing plant at its French site in Lamotte into operation.

INCOG Biopharma has completed the construction of its cleanroom production area, marking a milestone in the completion of an overall $100 million investment in a new facility.

Catalent has acquired the Vaccine Manufacturing Innovation Centre in Harwell, Oxford to expand its biologics capabilities across the UK and Europe.

Merck has expanded its manufacturing facility in Elkton, Va. to further increase its HPV vaccine supply.

Standardization is needed in CAR-T cell therapy development due to its inherent complexity.

ten23 health is expanding its sterile drug product manufacturing site at Visp, Switzerland to enlarge cold storage and visual inspections capacity and add clean rooms.

Sterling Pharma Solutions has unveiled a £1 million expansion project to increase its capabilities and laboratories capacity at its Deeside, UK site.

UK government has awarded chemical producer Croda a £15.9 million grant to increase the UK’s capacity to manufacture key vaccine ingredients.

Lonza has joined IPAC-RS, providing benefits to Lonza’s inhalation- related businesses due to IPAC-RS’ global voice of the orally inhaled and nasal drug products industry.

In this episode of the Drug Solutions Podcast, Jennifer Markarian, manufacturing reporter, talks about continuous manufacturing of oral solid-dosage drugs with Lawrence De Belder, executive consultant at Pharmatech Associates, a USP company.

Collaboration and new tools aid efforts to implement new processing technologies for small-molecule drug product manufacturing.

Effective cleaning and disinfection along with contamination controls are imperative when operating and utilizing a cleanroom.

Meeting patient needs and achieving high quality are common goals for all stakeholders.

The continuous, aseptic fill/finish process is finding use in vaccines and biologic drugs.

Innovations address supply-chain constraints, serialization, and new requirements for sustainable and patient-centric designs.

ROSS Batch High Shear Mixers are a versatile tool for powder delivery and dispersion of low-viscosity liquids.

The PureVessel series provides modular storage, preparation, treatment, and mixing of liquids.

The DynaPro NanoStar II introduces advanced walk-up capabilities in DLS technology.

Rockwell Automations newest graphic terminals increase user storage, product security, and support for modern peripherals.

Symbiosis announced the successful completion of UK Research and Innovation project to enhance the manufacturing supply chain for ATMPs within the UK.

Thermo Fisher Scientific’s new Gibco CTS Xenon Electroporation System aims to provide easier scale up for cell therapies, from clinical development to commercial manufacturing.

KeyPlants has shipped a first-of-its-kind vaccine manufacturing facility to Senegal in West Africa.